Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
February 2026
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Read more
5 Feb 2026
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
4 Feb 2026
Ultrasound-Detected Synovitis Linked to Functional Impairment in Hand Osteoarthritis
Data from the LIHOA cohort show that ultrasound-detected synovitis and synovial thickening in hand osteoarthritis are associated with worse hand function but not pain intensity.
2 Feb 2026
Cast Immobilisation for Unstable Ankle Fractures
Cast immobilisation proved non-inferior to surgery for the treatment of unimalleolar Weber B ankle fractures with a congruent mortise on initial radiography but deemed unstable by external rotation stress testing.
30 Jan 2026
Inflammatory Arthritis Can Emerge Years After Bariatric Surgery
A case series published in BMC Rheumatology describes new-onset inflammatory arthritis following bariatric surgery, with MRI-confirmed axial and peripheral disease requiring advanced treatment.
27 Jan 2026
Patients With Rheumatoid Arthritis Face Higher Thyroid Cancer Risk
Real-world data from TriNetX show patients with rheumatoid arthritis have a significantly increased risk of thyroid cancer, highlighting the need for awareness and surveillance.
27 Jan 2026
High-Intensity Exercise Improves Fatigue in Rheumatoid Arthritis
A randomized controlled trial shows high-intensity interval and strength exercise improves multidimensional fatigue and quality of life in people with rheumatoid arthritis, with benefits lasting 12 months.
26 Jan 2026
CAR-T Cell Therapy Induces Durable Remission in SLE
A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients with severe, treatment-refractory systemic lupus erythematosus.
24 Jan 2026
Rheumatoid Arthritis Linked to Higher Cardiovascular Disease Risk
UK Biobank data show people with rheumatoid arthritis have higher risks of heart disease, heart failure, and arrhythmias, with genetic analyses supporting causal links.
Loading posts...
1
2
3
…
83
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View